DKK2 epigenetic changes may play a key role in the development of cervical cancer, suggesting a potential value of DKK2 hypermethylation as a triage test for screening, early diagnosis, or predicting the risk of cervical cancer. This evidence concerns the gene DKK2 and cervical cancer.